(Q34210726)

31 July 2017

title

Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase (English)

1 reference

31 July 2017

1 reference

4

Johan Auwerx

0 references

author name string

Lluis Fajas

series ordinal

1

1 reference

31 July 2017

Stephanie Miard

series ordinal

2

1 reference

31 July 2017

Michael R Briggs

series ordinal

3

1 reference

31 July 2017

language of work or name

1 reference

1 July 2003

1 reference

Journal of Lipid Research

31 July 2017

published in

1 reference

31 July 2017

volume

44

1 reference

31 July 2017

issue

9

1 reference

31 July 2017

page(s)

1652-1659

1 reference

Cyclooxygenase 2 inhibitors: discovery, selectivity and the future

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

CREB activation induces adipogenesis in 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Prostacyclin IP receptor up-regulates the early expression of C/EBPbeta and C/EBPdelta in preadipose cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

E2Fs regulate adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Analysis of cell cycle arrest in adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Arachidonic acid metabolites of the lipoxygenase as well as the cyclooxygenase pathway may be involved in regulating preadipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Inhibition of adipose differentiation by 9 alpha, 11 beta-prostaglandin F2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

The pleiotropic functions of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

The organization, promoter analysis, and expression of the human PPARgamma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Prostacyclin as a potent effector of adipose-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Requirement and role of arachidonic acid in the differentiation of pre-adipose cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Peroxisome proliferator-activated receptor delta (PPARdelta )-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Cyclooxygenase-2: a target for the prevention and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Is obesity an inflammatory condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Transcriptional control of adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Peroxisome-proliferator-activated receptor delta mediates the effects of long-chain fatty acids on post-confluent cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

Differential expression of prostaglandin receptor mRNAs during adipose cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300248-JLR200

10.1194/JLR.M300248-JLR200

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference